The global digestive enzymes market revenue was around US$ 760.24 million in 2022 and is estimated to reach US$ 1,610.7 million by 2031, growing at a compound annual growth rate (CAGR) of 8.7% during the forecast period from 2023 to 2031.
Digestive enzymes are proteins that assist in breaking down food substances like proteins, fats, and carbohydrates into smaller molecules that can be absorbed by the body. It takes some time to complete this process and outcomes in glycerol, amino acids, fatty acids, and simple sugars. Digestive enzymes play a crucial role in providing proper nutrient absorption and digestion.
Market Driving Factors
The increasing focus on preventive healthcare and increasing health consciousness among consumers is a main factor propelling the market growth. This is due to the consumers becoming surging aware of the importance of gut health and its impact on overall health. In addition, the gut microbiome plays an essential role in metabolism, immune function, vitamin synthesis, and more. As a result, surging demand for products that support gut function and digestive health. Therefore, consumer preference is shifting towards digestive supplements as a means of managing digestive conditions, enhancing nutrient absorption, and maintaining overall health.
Advancements in enzyme engineering technologies are estimated to drive the market. This is mainly due to the advancements in biotechnology and enzyme engineering that are improving the specificity, stability, and efficiency of digestive enzymes. In addition, the usage of protein engineering and recombinant DNA technology has led to the development of enhanced enzyme formulations. As a result, these advances are overcoming difficulties like enzyme inactivation and are facilitating the development of highly potent and targeted digestive enzyme supplements.
The increase in the geriatric population worldwide presents significant possibilities for the digestive enzymes market. This is primarily owing to age-related digestive problems such as fewer stomach acid production, slower transit times, and reduced enzyme secretion leading to impaired digestion and nutrient absorption in senior citizens. Thus, this boosts the demand for digestive enzyme supplements to enhance gut function.
Innovation in enzyme extraction processes is expected to drive the market. This is because manufacturers are creating innovative extraction and purification processes such as chromatography, ultrafiltration, and cold extraction to acquire enzymes in their most active forms. In addition, these advanced enzyme extraction techniques produce purified enzymes and highly concentrated formulations. Therefore, manufacturers are deriving enzymes from new sources such as yeast and fungi utilizing fermentation technology. Such innovations in enzyme extraction and processing are enhancing enzyme quality.
High expenses of enzyme extraction and processing hamper the market.
Regional Analysis
North America dominated the market in terms of the highest revenue. This can be attributed to the rapid advances in enzyme products, rise in investments in research & development activities, and surge in the patient pool.
Asia-Pacific is estimated to dominate the market in terms of the growth rate. This is mainly owing to the increase in incidences of digestive disorders such as pancreatic and pancreatitis cancer.
Europe is predicted to dominate the market in terms of the largest shares. This is owing to the high demand for preventive healthcare products, the established supplement industry, and the increasing geriatric population.
Segmentation Insights
Origin Insight
The microbial segment dominates the market in terms of revenue. This is due to trends such as an increase in demand for microbial enzymes and a rise in patient awareness toward effective & cutting-edge technologies. Additionally, an increase in the number of cases of digestive disorders leads to a surge in demand for enzymes. Thus, this factor drives the segment growth.
Enzyme Type Insight
The carbohydrase segment is estimated to dominate the market in terms of revenue. This is due to the increase in the number of products available with carbohydrate enzymes and the rise in the geriatric population facing digestive issues.
Application Insight
The prescription medicine segment dominates the market in terms of the largest share. This is primarily due to the increase in the prevalence of digestive disorders, which increase in the usage of prescription medicines as supplemental support, and a surge in emphasis on preventive disease management.
The sports nutrition segment is predicted to dominate the market in terms of growth rate. This is due to the increase in the number of fitness centers & gymnasiums and the surge in awareness about gastrointestinal (GI) health.
Prominent Companies
Segmentation Outline
The global digestive enzymes market segmentation focuses on the Origin, Enzyme Type, Application, and Region.
By Origin
By Enzyme Type
By Application
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL DIGESTIVE ENZYMES MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: DIGESTIVE ENZYMES MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL DIGESTIVE ENZYMES MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL DIGESTIVE ENZYMES MARKET, BY ORIGIN
5.1 OVERVIEW
5.2 ANIMAL
5.3 MICROBIAL
5.4 PLANT
6 GLOBAL DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE
6.1 OVERVIEW
6.2 CARBOHYDRASE
6.3 PROTEASE
6.4 LIPASE
6.5 OTHERS
7 GLOBAL DIGESTIVE ENZYMES MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 PRESCRIPTION MEDICINE
7.3 SPORTS NUTRITION
7.4 INFANT NUTRITION
8 GLOBAL DIGESTIVE ENZYMES MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3.1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL DIGESTIVE ENZYMES MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 COUNTRY LIFE LLC
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 ABBVIE INC
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 BIOTICS RESEARCH CORPORATION
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 GARDEN OF LIFE INC.
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 METAGENICS INC.
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 AMWAY CORPORATION
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 ALLERGAN PLC
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 ARCHER DANIELS MIDLAND COMPANY
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 ABBOTT NUTRITION
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 JOHNSON & JOHNSON
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved